Answers are grounded in this paper and cite their sources.
Review highlights sex-dimorphic neuroprotection and high hepatic clearance of allopregnanolone, indicating a need for synthetic analogues in neurological disorders.
Allopregnanolone, a 3α,5α-progesterone metabolite, acts as a potent allosteric modulator of the γ-aminobutyric acid type A receptor. In the present review, the synthesis of this neuroactive steroid occurring in the nervous system is discussed with respect to physiological and pathological conditions. In addition, its physiological and neuroprotective effects are also reported. Interestingly, the levels of this neuroactive steroid, as well as its effects, are sex-dimorphic, suggesting a possible gender medicine based on this neuroactive steroid for neurological disorders. However, allopregnanolone presents low bioavailability and extensive hepatic metabolism, limiting its use as a drug. Therefore, synthetic analogues or a different therapeutic strategy able to increase allopregnanolone levels have been proposed to overcome any pharmacokinetic issues.
No takes yet. Share an insight, caveat, or question.
Diviccaro et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: